Added to YB: 2025-09-09
Pitch date: 2025-07-23
DGX [bullish]
Quest Diagnostics Incorporated
+20.98%
current return
Author Info
No bio for this author
Company Info
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.
Market Cap
$23.0B
Pitch Price
$170.99
Price Target
230.00 (+10%)
Dividend
1.64%
EV/EBITDA
10.88
P/E
23.92
EV/Sales
2.64
Sector
Health Care Providers and Services
Category
growth
Quest Diagnostics Incorporated - $DGX
DGX: Duopoly w/ LabCorp in clinical testing serving 50% hospitals, 33% US adults. Trades cheap despite recurring revenue from chronic disease tailwinds & early detection trends. 2026 est: $11.2B revenue, $2.3B EBITDA, $1.2B FCF. EPS $10.50+ by 2026, $11.50+ 2027. 20x P/E = $230 target. Catalysts: unhealthier population driving test demand.
Read full article (4 min)